Piotr Kosson

Piotr Kosson

Auto-generated profile, based on publicly available information

Piotr Kosson

Toxicology Research Laboratory, Mossakowski Medical Research Centre Polish Academy of Sciences, Pawińskiego 5, 02-106 Warsaw, Poland

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

19 February 2019 in Molecules
Verified
Journal Article
Open access
PDF file
PLPiotr Lipiński
Piotr Lipiński
PKPiotr Kosson
Piotr Kosson
JMJoanna Matalińska
Joanna Matalińska
PRPiotr Roszkowski
Piotr Roszkowski
Zbigniew CzarnockiZbigniew Czarnocki
Zbigniew Czarnocki
JSJoanna Sadlej
Joanna Sadlej
Interactions of 21 fentanyl derivatives with μ-opioid receptor (μOR) were studied using experimental and theoretical methods. Their binding to μOR was assessed with radioligand competitive binding assay. A uniform set of binding affinity data contains values for two novel and one previously uncharacterized derivative. The data confirms trends known so far and thanks to their uniformity, they facilitate further comparisons. In order to provide structural hypotheses explaining the experimental affinities, the complexes of the studied derivatives with μOR were modeled and subject to molecular dynamics simulations. Five common General Features (GFs) of fentanyls’ binding modes stemmed from these simulations. They include: GF1) the ionic interaction between D147 and the ligands’ piperidine NH+ moiety; GF2) the N-chain orientation towards the μOR interior; GF3) the other pole of ligands is directed towards the receptor outlet; GF4) the aromatic anilide ring penetrates the subpocket formed by TM3, TM4, ECL1 and ECL2; GF5) the 4-axial substituent (if present) is directed towards W318. Except for the ionic interaction with D147, the majority of fentanyl-μOR contacts is hydrophobic. Interestingly, it was possible to find nonlinear relationships between the binding affinity and the volume of the N-chain and/or anilide’s aromatic ring. This kind of relationships is consistent with the apolar character of interactions involved in ligand–receptor binding. The affinity reaches the optimum for medium size while it decreases for both large and small substituents. Additionally, a linear correlation between the volumes and the average dihedral angles of W293 and W133 was revealed by the molecular dynamics study. This seems particularly important, as the W293 residue is involved in the activation processes. Further, the Y326 (OH) and D147 (Cγ) distance found in the simulations also depends on the ligands’ size. In contrast, neither RMSF measures nor D114/Y336 hydrations show significant structure-based correlations. They also do not differentiate studied fentanyl derivatives. Eventually, none of 14 popular scoring functions yielded a significant correlation between the predicted and observed affinity data (R < 0.30, n = 28).

26 August 2016 in Virology Journal
Verified
Journal Article
Open access
PDF file
ASAnna Stachyra
Anna Stachyra
PRPatrycja Redkiewicz
Patrycja Redkiewicz
PKPiotr Kosson
Piotr Kosson
APAnna Protasiuk
Anna Protasiuk
AGAnna Góra-Sochacka
Anna Góra-Sochacka
Agnieszka SirkoAgnieszka Sirko
Agnieszka Sirko
Highly pathogenic avian influenza viruses are a serious threat to domestic poultry and can be a source of new human pandemic and annual influenza strains. Vaccination is the main strategy of protection against influenza, thus new generation vaccines, including DNA vaccines, are needed. One promising approach for enhancing the immunogenicity of a DNA vaccine is to maximize its expression in the immunized host. The immunogenicity of three variants of a DNA vaccine encoding hemagglutinin (HA) from the avian influenza virus A/swan/Poland/305-135V08/2006 (H5N1) was compared in two animal models, mice (BALB/c) and chickens (broilers and layers). One variant encoded the wild type HA while the other two encoded HA without proteolytic site between HA1 and HA2 subunits and differed in usage of synonymous codons. One of them was enriched for codons preferentially used in chicken genes, while in the other modified variant the third position of codons was occupied in almost 100 % by G or C nucleotides. The variant of the DNA vaccine containing almost 100 % of the GC content in the third position of codons stimulated strongest immune response in two animal models, mice and chickens. These results indicate that such modification can improve not only gene expression but also immunogenicity of DNA vaccine. Enhancement of the GC content in the third position of the codon might be a good strategy for development of a variant of a DNA vaccine against influenza that could be highly effective in distant hosts, such as birds and mammals, including humans.

1 January 2017 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
PDF file
Marek KonopMarek Konop
Marek Konop
DSDorota Sulejczak
Dorota Sulejczak
JCJoanna Czuwara
Joanna Czuwara
PKPiotr Kosson
Piotr Kosson
AMAleksandra Misicka
Aleksandra Misicka
LRLidia Rudnicka
Lidia Rudnicka

1 January 2006 in Peptides
Verified
Journal Article
Closed access
AJAnna Janecka
Anna Janecka
RKRafal Kruszynski
Rafal Kruszynski
JFJakub Fichna
Jakub Fichna
PKPiotr Kosson
Piotr Kosson
Tomasz JaneckiTomasz Janecki
Tomasz Janecki

1 January 2010 in Molecular Pain
Verified
Journal Article
Open access
Patrycja KleczkowskaPatrycja Kleczkowska
Patrycja Kleczkowska
PKPiotr Kosson
Piotr Kosson
SBSteven Ballet
Steven Ballet
IEIsabelle Van Den Eynde
Isabelle Van Den Eynde
YTYuko Tsuda
Yuko Tsuda
ALAndrzej W Lipkowski
Andrzej W Lipkowski
Background: The clinical treatment of various types of pain relies upon the use of opioid analgesics. However most of them produce, in addition to the analgesic effect, several side effects such as the development of dependence and addiction as well as sedation, dysphoria, and constipation. One solution to these problems are chimeric compounds in which the opioid pharmacophore is hybridized with another type of compound to incease antinociceptive effects. Neurotensin-induced antinociception is not mediated through the opioid system. Therefore, hybridizing neurotensin with opioid elements may result in a potent synergistic antinociceptor.Results: Using the known structure-activity relationships of neurotensin we have synthesized a new chimeric opioid-neurotensin compound PK20 which is characterized by a very strong antinociceptive potency. The observation that the opioid antagonist naltrexone did not completely reverse the antinociceptive effect, indicates the partial involvement of the nonopioid component in PK20 in the produced analgesia.Conclusions: The opioid-neurotensin hybrid analogue PK20, in which opioid and neurotensin pharmacophores overlap partially, expresses high antinociceptive tail-flick effects after central as well as peripheral applications.